BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29571273)

  • 81. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.
    Delea T; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
    J Support Oncol; 2006; 4(7):341-7. PubMed ID: 16892696
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder.
    Schein J; Cloutier M; Gauthier-Loiselle M; Bungay R; Chen K; Chan D; Childress A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):588-598. PubMed ID: 38824634
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.
    Merola JF; Herrera V; Palmer JB
    Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Matched cohort study of healthcare resource utilization and costs in young children of mothers with postpartum depression in the United States.
    Moore Simas TA; Huang MY; Packnett ER; Zimmerman NM; Moynihan M; Eldar-Lissai A
    J Med Econ; 2020 Feb; 23(2):174-183. PubMed ID: 31597499
    [No Abstract]   [Full Text] [Related]  

  • 85. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
    Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
    BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Economic burden of osteoporosis-related fractures in Medicaid.
    Rousculp MD; Long SR; Wang S; Schoenfeld MJ; Meadows ES
    Value Health; 2007; 10(2):144-52. PubMed ID: 17391423
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy.
    Terpos E; Jamotte A; Christodoulopoulou A; Campioni M; Bhowmik D; Kennedy L; Willenbacher W
    J Med Econ; 2019 Aug; 22(8):766-776. PubMed ID: 30969797
    [No Abstract]   [Full Text] [Related]  

  • 88. Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma.
    Wu EQ; Bensimon AG; Marynchenko M; Namjoshi M; Guo A; Yu AP; Ericson SG; Raje N
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):326-35. PubMed ID: 21700528
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study.
    Lüftner D; Lorusso V; Duran I; Hechmati G; Garzon-Rodriguez C; Ashcroft J; Bahl A; Ghelani P; Wei R; Thomas E; Hoefeler H
    Springerplus; 2014; 3():328. PubMed ID: 25045611
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.
    Delea TE; McKiernan J; Brandman J; Edelsberg J; Sung J; Raut M; Oster G
    J Thorac Oncol; 2006 Jul; 1(6):571-6. PubMed ID: 17409919
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The cost of treating skeletal-related events in patients with prostate cancer.
    Lage MJ; Barber BL; Harrison DJ; Jun S
    Am J Manag Care; 2008 May; 14(5):317-22. PubMed ID: 18471035
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study.
    Baek YH; Jeon HL; Oh IS; Yang H; Park J; Shin JY
    Cancer Epidemiol; 2019 Aug; 61():104-110. PubMed ID: 31176960
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis.
    Zhou Z; Fan Y; Thomason D; Tang W; Liu X; Zhou ZY; Macaulay D; Fischer A
    Adv Ther; 2019 May; 36(5):1100-1113. PubMed ID: 30929184
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.
    Amos TB; Tandon N; Lefebvre P; Pilon D; Kamstra RL; Pivneva I; Greenberg PE
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474009
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study.
    Lee JY; Lee JH; Seo J; Kang M; Jung EH; Kim SA; Suh KJ; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Lee JS; Bang SM
    J Korean Med Sci; 2024 Jun; 39(22):e175. PubMed ID: 38859738
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis.
    Cappell K; Taylor A; Johnson BH; Gelwicks S; Wang S; Gerber M; Leffler DA
    Am J Gastroenterol; 2020 Nov; 115(11):1821-1829. PubMed ID: 33156101
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
    Hepp Z; Lage MJ; Espaillat R; Gossain VV
    J Med Econ; 2018 Sep; 21(9):912-919. PubMed ID: 29865926
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.
    Body JJ; Acklin YP; Gunther O; Hechmati G; Pereira J; Maniadakis N; Terpos E; Finek J; von Moos R; Talbot S; Sleeboom H
    J Bone Oncol; 2016 Nov; 5(4):185-193. PubMed ID: 28008381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.